Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 48 out of 100. Brain scans and imaging

Topic: Amyloid, tau and blood-test diagnosis

Alzheimer's Disease (AD) is a progressive condition of a neurological brain disorder recognized by symptoms such as dementia, memory loss, alterations in behaviour, and impaired reasoning abilities. Recently, many researchers have been working to develop an effective AD recognition system using deep learning (DL) based convolutional neural network (CNN) model aiming to deploy the automatic medical image diagnosis system. The existing system is still facing difficulties in achieving satisfactory performance in terms of accuracy and efficiency because of the lack of feature ineffectiveness. This study proposes a lightweight Stacked Convolutional Neural Network with a Channel Attention Network (SCCAN) for MRI based on AD classification to overcome the challenges. In the procedure, we sequentially integrate 5 CNN modules, which form a stack CNN aiming to generate a hierarchical understanding of features through multi-level extraction, effectively reducing noise and enhancing the weight's efficacy. This feature is then fed into a channel attention module to select the practical features based on the channel dimension, facilitating the selection of influential features. . Consequently, the model exhibits reduced parameters, making it suitable for training on smaller datasets. Addressing the class imbalance in the Kaggle MRI dataset, a balanced distribution of samples among classes is emphasized. Extensive experiments of the proposed model with the ADNI1 Complete 1Yr 1.5T, Kaggle, and OASIS-1 datasets showed 99.58%, 99.22%, and 99.70% accuracy, respectively. The proposed model's high performance surpassed state-of-the-art (SOTA) models and proved its excellence as a significant advancement in AD classification using MRI images.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Hassan, N., Miah, A. S. M., Suzuki, K., Okuyama, Y., & Shin, J. (2025). Stacked CNN-based multichannel attention networks for Alzheimer disease detection. Scientific Reports. https://doi.org/10.1038/s41598-025-85703-x

Vancouver

Hassan N, Miah ASM, Suzuki K, Okuyama Y, Shin J. Stacked CNN-based multichannel attention networks for Alzheimer disease detection. Scientific Reports. 2025. doi:10.1038/s41598-025-85703-x. PMID: 39962097.

BibTeX

@article{hassan2025-39962097,
  author  = {Hassan, Najmul and Miah, Abu Saleh Musa and Suzuki, Kota and Okuyama, Yuichi and Shin, Jungpil},
  title   = {{Stacked CNN-based multichannel attention networks for Alzheimer disease detection}},
  journal = {Scientific Reports},
  year    = {2025},
  doi     = {10.1038/s41598-025-85703-x},
  pmid    = {39962097},
  url     = {https://doi.org/10.1038/s41598-025-85703-x}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This study proposes a lightweight neural network for classifying Alzheimer's disease from MRI images and reports that it surpassed other models. It is a technical classification study and does not test any treatment, cure, or prevention.

Study details

How this study scored 48/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 4 of 7; Citations per year 3 of 5; Impact for its field and year 5 of 6; Cited by studies here 1 of 6; Still being cited 2 of 4; Senior author's track record 2 of 4; Institution's track record 0 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 48 of 100.48 of 100 points earned52 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Scientific Reports)
Journal's citation record 3 / 4 Scientific Reports: journal h-index 463 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 4 / 7 Cited 41 times (OpenAlex, 2026-10-10)
Citations per year 3 / 5 13.7 citations a year over 3 year(s) since 2025
Impact for its field and year 5 / 6 Cited 26.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 2 / 4 Cited 41 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Jungpil Shin: h-index 39 (OpenAlex, whole career)
Institution's track record 0 / 3 University of Aizu: institution h-index 183 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 39962097)
Free to read 2 / 2 Free to read
Total 48 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Brain scans and imaging

Also tagged “classification”

835 studies in the library carry the topic tag “classification”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 835 tagged studies.

Similar studies

More on Brain scans and imaging

See all studies in Brain scans and imaging →